Skip to main content

Research and statistics

Skip to results
364 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Quarterly reports on acquired carbapenemase-producing Gram-negative organisms (CPOs) identified in human samples in England.

  • Evaluation of the Shingrix® herpes zoster (shingles) vaccination programme in England: academic year 2023 to 2024.

  • Annual counts and rates of Escherichia coli (E. coli) bacteraemia by acute trust and sub-integrated care board location (SICBL).

  • Annual counts and rates of meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

  • Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.

  • Annual counts and rates of C. difficile infections (CDI) by acute trust and sub-integrated care board location (SICBL) in patients aged 2 years and over.

  • Annual counts and rates of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).

  • Annual counts and rates of Klebsiella species (Klebsiella spp.) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).

  • Technical briefing documents on the investigation into cases of mpox in England.

  • Measles notifications and deaths in England and Wales.

  • Latest UKHSA hepatitis B virus report and supporting document for England.

  • An examination of the epidemiology of syphilis in England presented by demographic characteristics to illustrate how different groups are affected.

  • A yearly overview of influenza surveillance results from the winter period.

  • Epidemiological information relating to ceftriaxone-resistant Neisseria gonorrhoeae in England.

  • Evaluation report on uptake of the measles, mumps and rubella (MMR) vaccine during national and regional MMR catch-up activities in 2023 to 2024 in England.

  • Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England.

  • Annual data on reported cases of diphtheria in England, with epidemiological commentary.

  • Laboratory reports on cases of Haemophilus influenzae in England.

  • Number of laboratory confirmed cases of parvovirus B19 infection in women aged 15 to 44 years in England.

  • Evaluation of the eleventh year of the Zostavax® shingles vaccination programme in England: financial year 2023 to 2024.